Massimo De Giorgio

1.3k total citations
15 papers, 451 citations indexed

About

Massimo De Giorgio is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Massimo De Giorgio has authored 15 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Massimo De Giorgio's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (5 papers) and Renal cell carcinoma treatment (4 papers). Massimo De Giorgio is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (5 papers) and Renal cell carcinoma treatment (4 papers). Massimo De Giorgio collaborates with scholars based in Italy, United States and Latvia. Massimo De Giorgio's co-authors include Franco Trevisani, Carmela Cursaro, Franco Borzio, Luisa Benvegnù, Dario Marino, Fabio Farinati, Mauro Bernardi, Gianludovico Rapaccini, Maria Anna Di Nolfo and A. Baldan and has published in prestigious journals such as Journal of Hepatology, The American Journal of Gastroenterology and Transplantation.

In The Last Decade

Massimo De Giorgio

11 papers receiving 440 citations

Peers

Massimo De Giorgio
Poh Seng Tan Singapore
Hiroaki Hagihara Japan
VJ Desmet Belgium
Moon Soo Koh South Korea
Neus Llarch Spain
Ning‐Fu Peng China
Diyang Xie China
K Shirabe Japan
Zhang Cheng China
G.K. Abou-Alfa United States
Poh Seng Tan Singapore
Massimo De Giorgio
Citations per year, relative to Massimo De Giorgio Massimo De Giorgio (= 1×) peers Poh Seng Tan

Countries citing papers authored by Massimo De Giorgio

Since Specialization
Citations

This map shows the geographic impact of Massimo De Giorgio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo De Giorgio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo De Giorgio more than expected).

Fields of papers citing papers by Massimo De Giorgio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo De Giorgio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo De Giorgio. The network helps show where Massimo De Giorgio may publish in the future.

Co-authorship network of co-authors of Massimo De Giorgio

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo De Giorgio. A scholar is included among the top collaborators of Massimo De Giorgio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo De Giorgio. Massimo De Giorgio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Muglia, Riccardo, Massimo De Giorgio, Paolo Marra, et al.. (2025). Long-term outcomes of Yttrium-90 transarterial radioembolization for patients with hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3114–3124.
2.
Viganò, Mauro, et al.. (2023). Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer. Cancers. 15(6). 1766–1766. 21 indexed citations
3.
Giorgio, Massimo De, et al.. (2023). Long term outcome of patients with hepatocellular carcinoma treated with transarterial radioembolization. Digestive and Liver Disease. 55. S219–S219.
4.
5.
Tovoli, Francesco, Vito Sansone, Massimo Iavarone, et al.. (2022). Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments. Transplantation. 107(1). 156–161. 8 indexed citations
6.
Magro, Bianca, D. Pinelli, Massimo De Giorgio, et al.. (2021). Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan Criteria. Cancers. 13(23). 5976–5976. 6 indexed citations
7.
8.
Lucà, Maria Grazia, Roberto Nani, Melanie Schranz, et al.. (2018). Treatment of Hepatocellular Carcinoma: A Cost Analysis Of Yttrium-90 Transarterial Radioembolization Versus Sorafenib. Future Oncology. 14(8). 727–735. 4 indexed citations
9.
Pecorelli, Anna, Roberto Nani, D. Pinelli, et al.. (2017). Validation of Liver Imaging Reporting and Data System (LI-RADS) Version 2014. Digestive and Liver Disease. 49(1). e49–e49.
10.
Carr, Brian I., Vito Guerra, Massimo De Giorgio, S. Fagiuoli, & Petr Pančoška. (2012). Small Hepatocellular Carcinomas and Thrombocytopenia. Oncology. 83(6). 331–338. 21 indexed citations
11.
Pančoška, Petr, Massimo De Giorgio, S. Fagiuoli, & Brian I. Carr. (2011). Small HCCs Identified by Screening. Digestive Diseases and Sciences. 56(10). 3078–3085. 7 indexed citations
12.
Cabibbo, Giuseppe, Emanuela Rolle, Massimo De Giorgio, et al.. (2011). Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib. Expert Review of Anticancer Therapy. 11(12). 1807–1816. 18 indexed citations
13.
Giorgio, Massimo De, Stefano Vezzoli, Eric Cohen, et al.. (2010). Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transplantation. 16(4). 503–512. 34 indexed citations
14.
Farinati, Fabio, Dario Marino, Massimo De Giorgio, et al.. (2006). Diagnostic and Prognostic Role of alpha-Fetoprotein in Hepatocellular Carcinoma: Both or Neither?. The American Journal of Gastroenterology. 101(3). 524–532. 330 indexed citations
15.
Cianci, Rossella, Giovanni Cammarota, J. Galli, et al.. (2000). Is the alkaline reflux a risk factor for laryngeal lesions?. Digestive and Liver Disease. 32. A117–A117. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Poh Seng Tan Breakdown of academic impact, for papers by Hiroaki Hagihara Breakdown of academic impact, for papers by VJ Desmet Breakdown of academic impact, for papers by Moon Soo Koh Breakdown of academic impact, for papers by Neus Llarch Breakdown of academic impact, for papers by Ning‐Fu Peng Breakdown of academic impact, for papers by Diyang Xie Breakdown of academic impact, for papers by K Shirabe Breakdown of academic impact, for papers by Zhang Cheng Breakdown of academic impact, for papers by G.K. Abou-Alfa
Rankless by CCL
2026